AI English summary of an SEC filing — figures as filed
Zimmer Biomet ZBHOn June 28, 2024, the company entered into a 5-year unsecured revolving credit agreement for $1.5 billion with JPMorgan Chase Bank, N.A. as administrative agent, maturing on June 28, 2029. The company said borrowings will be used for general corporate purposes.
Key points
AI summaryOn June 28, 2024, the company entered into a 5-year unsecured revolving credit agreement for $1.5 billion with JPMorgan Chase Bank, N.A. as administrative agent, maturing on June 28, 2029. The company said borrowings will be used for general corporate purposes.
The company also entered into an unsecured 364-Day revolving credit agreement on the same day, with a principal amount of $1.0 billion, maturing on June 27, 2025. The company said borrowings will be used for general corporate purposes.
In connection with the new agreements, the company terminated its existing 5-year agreement and its 364-Day agreement on June 28, 2024, effective as of July 7, 2023, the company said, and there were no outstanding borrowings at the time of termination. The company said letters of credit under the existing 5-year agreement were transferred to the new 5-year agreement.
The company said both agreements bear floating interest based on adjusted Term SOFR or an alternate base rate, plus a margin tied to its senior unsecured long-term debt credit rating. It said it must maintain a ratio of consolidated indebtedness to consolidated EBITDA of no greater than 4.5 to 1.0. The ratio may increase to 5.0 to 1.0 in connection with a qualified material acquisition.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Company Enters Into 5-Year Unsecured Revolving Credit Agreement for $1.5 billion
On June 28, 2024, the company entered into a 5-year unsecured revolving credit agreement for $1.5 billion with JPMorgan Chase Bank, N.A. as administrative agent, maturing on June 28, 2029. The company said borrowings will be used for general corporate purposes.
Source · Based on the filing body and exhibits
Company Enters Into 364-Day Revolving Credit Agreement for $1.0 billion
The company also entered into an unsecured 364-Day revolving credit agreement on the same day, with a principal amount of $1.0 billion, maturing on June 27, 2025. The company said borrowings will be used for general corporate purposes.
Source · Based on the filing body and exhibits
Existing 2023 Credit Agreement Terminated and Letters of Credit Transferred
In connection with the new agreements, the company terminated its existing 5-year agreement and its 364-Day agreement on June 28, 2024, effective as of July 7, 2023, the company said, and there were no outstanding borrowings at the time of termination. The company said letters of credit under the existing 5-year agreement were transferred to the new 5-year agreement.
Source · Based on the filing body and exhibits
Interest Rate Structure and Financial Covenant (Leverage Ratio Limit)
The company said both agreements bear floating interest based on adjusted Term SOFR or an alternate base rate, plus a margin tied to its senior unsecured long-term debt credit rating. It said it must maintain a ratio of consolidated indebtedness to consolidated EBITDA of no greater than 4.5 to 1.0. The ratio may increase to 5.0 to 1.0 in connection with a qualified material acquisition.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…